⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
AI Visibility Scorecard
Relapsed or Refractory Multiple Myeloma Treatment
kyprolis.com · Healthcare
Somewhat visible. AI bots can read Relapsed or Refractory Multiple Myeloma Treatment, but it is missing the structured signals that push citation rate above competitors.
AI engines read this profile 1 times
Claude
#143,942 of 835,694 in Healthcare for AI visibility
5.6
/10
AEO Score
About Relapsed or Refractory Multiple Myeloma Treatment
from our crawl and measurement
Relapsed or Refractory Multiple Myeloma Treatment is a business whose own site puts it this way: "Discover KYPROLIS® (carfilzomib), a multiple myeloma treatment option for adults who have already received 1 or more previous treatments. See Full Safety & Prescribing Info." Its AI visibility score is 5.6 out of 10: the engines can find it, but they do not have much to hold on to.
Our crawl found a sitemap. It is missing structured data describing the business, an llms.txt file and a heading structure that lays out what it offers.
AI crawlers have visited once in our tracking, including ClaudeBot (Anthropic).
The 6 signals AI reads
Higher is better · 0-10
Structured Data
1
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
7
Clear headings and answer-style content.
Entity Clarity
4
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
0
Experience, Expertise, Authority, Trust markers.
Technical AEO
7
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
6
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
9
Inbound links from other sites.
Domain Authority
3
Established authority for your domain.
Reference Presence
0
Not in AI knowledge graphs yet.
News & Press
0
No press coverage found yet.
Community
0
No community discussion yet.
Social Mentions
0
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 5.6/10, Relapsed or Refractory Multiple Myeloma Treatment has a working base to build on - fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for Relapsed or Refractory Multiple Myeloma Treatment
Which AI engines already crawl you
Weekly ChatGPT & Claude citation tracking
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Relapsed or Refractory Multiple Myeloma Treatment.
Source & Attribution
Scored by Engagemii on August 7, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/kyprolis
Cite this score: Engagemii (2026). "AEO Score for Relapsed or Refractory Multiple Myeloma Treatment." Retrieved from https://engagemii.com/aeo/brands/kyprolis
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform